Discovery of a Novel Benzothiadiazine-Based Selective Aldose Reductase Inhibitor as Potential Therapy for Diabetic Peripheral Neuropathy.
- Resource Type
- Academic Journal
- Source
Diabetes (DIABETES), Mar2024; 73(3): 497-510. (14p)- Subject
- Language
- English
- ISSN
- 0012-1797